It’s an exciting time for new TB vaccine development! Several vaccine candidates are in late stage product development, with Phase III trial data available as early as 2024 and potential licensure and use in some countries in the near future. However, none of the candidates are expected to be a ‘silver bullet’ and there are differences in terms of trial design, primary endpoint, target population, and product attributes. Without a known correlate of protection, the effect of HIV status, infection status, age and geography on vaccine efficacy must be determined for each vaccine. We also need to ensure that the early pipeline remains robust in terms of new antigenic targets and platforms, and that new tools are developed to effectively evaluate their potential efficacy.
This webinar brought together experts to discuss the status of TB vaccine development across the value chain, from articulation of the public health and economic need for new TB vaccines, through the status and strategies for product development, to the considerations for approval, policy recommendation and use.
Année de publication
2024
GVIRF-webinar
Vous pouvez trouver plus d’informations sur "GVIRF-webinar" dans les rubriques suivantes :
| Titre | Auteur | Année | Type | Langue |
|---|
| 2021-10-14 mRNA Vaccine Technologies for Global Health - PRESENTATIONS | GVIRF Secretariat | 2021 | Presentation | Anglais |
| 2021-10-14 mRNA Vaccine Technologies for Global Health - VIDEO (corrected link) | GVIRF Secretariat | 2021 | Webinar | Anglais |
| 2022-03-03 Malaria Vaccine R&D and Immunization: Lessons Learned and Considerations for Global Health Impact - AGENDA | GVIRF Secretariat | 2022 | Presentation | Anglais |
| 2022-03-03 Malaria Vaccine R&D and Immunization Lessons Learned and Considerations for Global Health Impact - VIDEO | GVIRF Secretariat | 2022 | Webinar | Anglais |
| 2022-06-23 Vaccines as Tools to Prevent Antimicrobial Resistance: Advances, challenges, and future development - WEBINAR ANNOUNCEMENT | GVIRF Secretariat | 2022 | Presentation | Anglais |
| 2022-06-23 AMR: Vaccines as Tools to Prevent Antimicrobial Resistance: Advances, challenges, and future development - AGENDA | GVIRF Secretariat | 2022 | Presentation | Anglais |
| 2022-06-23 AMR: Vaccines as Tools to Prevent Antimicrobial Resistance - VIDEO | GVIRF Secretariat | 2022 | Webinar | Anglais, Français, Espagnol |
| 2022-10-12 Correlates of Protection - VIDEO (corrected link) | GVIRF Secretariat | 2022 | Webinar | Anglais |
| 2023-09-13 Webinar: Vaccine Adjuvants for Global Health - Final AGENDA | GVIRF Secretariat | 2023 | Webinar | Anglais |
| 2023-09-13 Webinar: Vaccine Adjuvants for Global Health - VIDEO | GVIRF Secretariat | 2023 | Webinar | Anglais |
| 2023-09-13 Webinar: Vaccine Adjuvants for Global Health - Session III Access to Adjuvants | GVIRF Secretariat | 2023 | Presentation | Anglais |
| 2023-09-13 Webinar: Vaccine Adjuvants for Global Health - Session I Global Demand for Vaccine Adjuvants | GVIRF Secretariat | 2023 | Presentation | Anglais |
| 2023-09-13 Webinar: Vaccine Adjuvants for Global Health - Session II Selection of Adjuvant and Formulation for Vaccine R&D: rational or empirical? | GVIRF Secretariat | 2023 | Presentation | Anglais |
| 2024-0222 GVIRF Webinar: New TB Vaccines for Adults and Adolescents, Progress, Prospects, and Perspectives, February 22, 2024 - ANNOUNCEMENT | GVIRF Secretariat | 2024 | Webinar | Anglais |
| 2024-0222 GVIRF Webinar: New TB Vaccines for Adults & Adolescents: Progress, Prospects and Perspectives; February 22, 2024 - FINAL AGENDA | GVIRF Secretariat | 2024 | Webinar | Anglais |
| 2024-0222 GVIRF Webinar: New TB Vaccines for Adults and Adolescents - VIDEO | GVIRF Secretariat | 2024 | Webinar | Anglais, Français, Espagnol |
| 2024-0222 GVIRF Webinar: New Tuberculosis Vaccines for Adults and Adolescents: Progress, Prospects, and Perspectives - PRESENTATIONS | GVIRF Secretariat, Richard White, Nebiat Gebreselassie, Mark Hatherill, Ann Ginsberg, Nicole Frahm, Munyaradzi Musvosvi, David Lewinsohn, Shelly Malhotra, Rupali Limaye, Birgitte Giersing | 2024 | Presentation | Anglais |
| 2024-0730 GVIRF Webinar: New Combination Vaccines; July 30, 2024 - AGENDA and REGISTRATION LINK | GVIRF Secretariat | 2024 | Webinar | Chinois, Anglais, Français, Portuguais, Espagnol |
| 2024-0730 GVIRF Webinar: New Combination Vaccines - PRESENTATIONS | GVIRF Secretariat | 2024 | Presentation | Anglais |
| 2024-0730 GVIRF Webinar: New Combination Vaccines - Questions and Answers | GVIRF Secretariat | 2024 | Webinar | Anglais |
| 2024-0730 GVIRF Webinar: New Combination Vaccines - VIDEO (corrected link) | GVIRF Secretariat | 2024 | Webinar | Chinois, Anglais, Français, Portuguais, Espagnol |
| 2024-1121 GVIRF Webinar: Artificial Intelligence (AI) in Vaccine Research & Development - ANNOUNCEMENT AND REGISTRATION LINK | GVIRF Secretariat | 2024 | Webinar | Anglais |
| 2024-1121 GVIRF Webinar: Artificial Intelligence (AI) in Vaccine Research & Development - VIDEO | GVIRF Secretariat | 2024 | Webinar | Anglais |
Ajouté par: Moderator
Ajouté le: 2024-03-05 14:03:01
Consultations: 2684
